Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Aug;77(2):221–225.

High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production.

J Deviere 1, J Content 1, C Denys 1, P Vandenbussche 1, L Schandene 1, J Wybran 1, E Dupont 1
PMCID: PMC1541981  PMID: 2505958

Abstract

Hypergammaglobulinaemia and enhanced serum IgA levels are common in alcoholic liver cirrhosis. Interleukin-6 (IL-6), which is identical to B cell differentiation factor BSF2 and is implicated in various autoimmune diseases, has been studied in patients with alcoholic liver cirrhosis. Increased serum levels and spontaneous or induced production of IL-6 by peripheral blood monoclonal cells have been found. IL-6 production correlates closely with IgA serum levels and negatively with impaired interleukin-2 and interferon gamma production. This abnormality could be related to overproduction of immunoglobulins and immune disturbances observed in this disease.

Full text

PDF
221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anastassakos C., Alexander G. J., Wolstencroft R. A., Avery J. A., Portmann B. C., Panayi G. S., Dumonde D. C., Eddleston A. L., Williams R. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology. 1988 Apr;94(4):999–1005. doi: 10.1016/0016-5085(88)90559-8. [DOI] [PubMed] [Google Scholar]
  2. Devière J., Denys C., Schandene L., Romasco F., Adler M., Wybran J., Dupont E. Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis. Clin Exp Immunol. 1988 Jun;72(3):377–382. [PMC free article] [PubMed] [Google Scholar]
  3. Enoch T., Zinn K., Maniatis T. Activation of the human beta-interferon gene requires an interferon-inducible factor. Mol Cell Biol. 1986 Mar;6(3):801–810. doi: 10.1128/mcb.6.3.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fuji A., Kakumu S., Ohtani Y., Murase K., Hirofuji H., Tahara H. Interferon-gamma production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology. 1987 May-Jun;7(3):577–581. doi: 10.1002/hep.1840070327. [DOI] [PubMed] [Google Scholar]
  5. Gauldie J., Richards C., Harnish D., Lansdorp P., Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7251–7255. doi: 10.1073/pnas.84.20.7251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Haegeman G., Content J., Volckaert G., Derynck R., Tavernier J., Fiers W. Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem. 1986 Sep 15;159(3):625–632. doi: 10.1111/j.1432-1033.1986.tb09931.x. [DOI] [PubMed] [Google Scholar]
  7. Hirano T., Taga T., Yasukawa K., Nakajima K., Nakano N., Takatsuki F., Shimizu M., Murashima A., Tsunasawa S., Sakiyama F. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci U S A. 1987 Jan;84(1):228–231. doi: 10.1073/pnas.84.1.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Houssiau F. A., Devogelaer J. P., Van Damme J., de Deuxchaisnes C. N., Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1988 Jun;31(6):784–788. doi: 10.1002/art.1780310614. [DOI] [PubMed] [Google Scholar]
  9. Huang Y. P., Perrin L. H., Miescher P. A., Zubler R. H. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol. 1988 Aug 1;141(3):827–833. [PubMed] [Google Scholar]
  10. Jirik F. R., Podor T. J., Hirano T., Kishimoto T., Loskutoff D. J., Carson D. A., Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol. 1989 Jan 1;142(1):144–147. [PubMed] [Google Scholar]
  11. Kawanishi H., Tavassolie H., MacDermott R. P., Sheagren J. N. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease. Gastroenterology. 1981 Mar;80(3):510–517. [PubMed] [Google Scholar]
  12. Kishimoto T., Hirano T. Molecular regulation of B lymphocyte response. Annu Rev Immunol. 1988;6:485–512. doi: 10.1146/annurev.iy.06.040188.002413. [DOI] [PubMed] [Google Scholar]
  13. Lumsden A. B., Henderson J. M., Kutner M. H. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology. 1988 Mar-Apr;8(2):232–236. doi: 10.1002/hep.1840080207. [DOI] [PubMed] [Google Scholar]
  14. MacSween R. N., Burt A. D. Histologic spectrum of alcoholic liver disease. Semin Liver Dis. 1986 Aug;6(3):221–232. doi: 10.1055/s-2008-1040605. [DOI] [PubMed] [Google Scholar]
  15. McKeever U., O'Mahony C., Whelan C. A., Weir D. G., Feighery C. Helper and suppressor T lymphocyte function in severe alcoholic liver disease. Clin Exp Immunol. 1985 Apr;60(1):39–48. [PMC free article] [PubMed] [Google Scholar]
  16. Muto Y., Nouri-Aria K. T., Meager A., Alexander G. J., Eddleston A. L., Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet. 1988 Jul 9;2(8602):72–74. doi: 10.1016/s0140-6736(88)90006-2. [DOI] [PubMed] [Google Scholar]
  17. Nijsten M. W., de Groot E. R., ten Duis H. J., Klasen H. J., Hack C. E., Aarden L. A. Serum levels of interleukin-6 and acute phase responses. Lancet. 1987 Oct 17;2(8564):921–921. doi: 10.1016/s0140-6736(87)91413-9. [DOI] [PubMed] [Google Scholar]
  18. Poupart P., Vandenabeele P., Cayphas S., Van Snick J., Haegeman G., Kruys V., Fiers W., Content J. B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). EMBO J. 1987 May;6(5):1219–1224. doi: 10.1002/j.1460-2075.1987.tb02357.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Prytz H., Holst-Christensen J., Korner B., Liehr H. Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis. Scand J Gastroenterol. 1976;11(8):857–863. [PubMed] [Google Scholar]
  20. Saxena S., Nouri-Aria K. T., Anderson M. G., Eddleston A. L., Williams R. Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon. Clin Exp Immunol. 1986 Mar;63(3):541–548. [PMC free article] [PubMed] [Google Scholar]
  21. Triger D. R., Wright R. Hyperglobulinaemia in liver disease. Lancet. 1973 Jun 30;1(7818):1494–1496. doi: 10.1016/s0140-6736(73)91827-8. [DOI] [PubMed] [Google Scholar]
  22. Van Damme J., Opdenakker G., Simpson R. J., Rubira M. R., Cayphas S., Vink A., Billiau A., Van Snick J. Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med. 1987 Mar 1;165(3):914–919. doi: 10.1084/jem.165.3.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Van Oers M. H., Van der Heyden A. A., Aarden L. A. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol. 1988 Feb;71(2):314–319. [PMC free article] [PubMed] [Google Scholar]
  24. Van Snick J., Cayphas S., Vink A., Uyttenhove C., Coulie P. G., Rubira M. R., Simpson R. J. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9679–9683. doi: 10.1073/pnas.83.24.9679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Van de Wiel A., Seifert W. F., Van der Linden J. A., Gmelig-Meyling F. H., Kater L., Schuurman H. J. Spontaneous IgA synthesis by blood mononuclear cells in alcoholic liver disease. Scand J Immunol. 1987 Feb;25(2):181–187. doi: 10.1111/j.1365-3083.1987.tb01062.x. [DOI] [PubMed] [Google Scholar]
  26. Wahl S. M., Hunt D. A., Bansal G., McCartney-Francis N., Ellingsworth L., Allen J. B. Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta. J Exp Med. 1988 Oct 1;168(4):1403–1417. doi: 10.1084/jem.168.4.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES